Drug Facts
Composition & Profile
Identifiers & Packaging
HOW SUPPLIED Betamethasone dipropionate ointment USP, 0.05% is supplied as follows: 15 g tubes NDC 52817-824-15 45 g tubes NDC 52817-824-45 Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from light and freezing.; PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 52817-824-45 Betamethasone Dipropionate Ointment USP, 0.05% (Potency expressed as Betamethasone ) FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. 45 g Rx only carton label
- HOW SUPPLIED Betamethasone dipropionate ointment USP, 0.05% is supplied as follows: 15 g tubes NDC 52817-824-15 45 g tubes NDC 52817-824-45 Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from light and freezing.
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 52817-824-45 Betamethasone Dipropionate Ointment USP, 0.05% (Potency expressed as Betamethasone ) FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. 45 g Rx only carton label
Overview
Betamethasone dipropionate ointment contains betamethasone dipropionate USP, a synthetic adrenocorticosteroid, for dermatologic use. Betamethasone, an analog of prednisolone, has a high degree of glucocorticoid activity and a slight degree of mineralocorticoid activity. Betamethasone dipropionate is a white to cream white odorless crystalline powder insoluble in water. Chemically, it is 9-fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17,21- dipropionate. The structural formula is: Each gram of the 0.05% ointment contains 0.64 mg betamethasone dipropionate (equivalent to 0.5 mg betamethasone) in an ointment base of mineral oil and white petrolatum. chemical-structure
Indications & Usage
Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage & Administration
Apply a thin film of betamethasone dipropionate ointment to the affected skin areas once daily. In some cases, twice daily dosage may be necessary. If an infection develops, appropriate antimicrobial therapy should be instituted. Betamethasone dipropionate ointment should not be used with occlusive dressings.
Warnings & Precautions
No warnings available yet.
Contraindications
Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Adverse Reactions
The following local adverse reactions are reported infrequently when betamethasone dipropionate ointment is used as recommended in the DOSAGE AND ADMINISTRATION section. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infections, skin atrophy, striae and miliaria. Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia and glucosuria in some patients.
Similar Drugs
Related medications based on brand, generic name, substance, active ingredients.